Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s revision stamp changed from v3.6.5 to v3.6.6, signaling a minor update to the site. No substantive study details or content appear to be changed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor release update to the page's version metadata rather than a content change.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page shows a new revision number (v3.6.4) replacing the previous one, indicating a lightweight platform update rather than a substantive change to the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, indicating a minor maintenance update to the page's metadata. No study content or results are affected.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now shows revision v3.6.2 in place of v3.6.0, indicating a routine site update. The change does not modify study details or interactions on the page.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page now shows that recruitment has ended, and additional navigation/help sections were added or updated to improve access to study information.SummaryDifference0.6%

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.